Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Studio OsseRvaziOnAle RelatIvo Al Follow-up a LuNGo Termine Di Pazienti Con Stenosi Aortica Severa Valutati Per Sostituzione Valvolare Aortica Percutanea (TAVI).

NCT06679517 is registered in ClinicalTrials.gov with University Hospital of Ferrara as lead sponsor.

NCT NCT06679517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06679517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Studio OsseRvaziOnAle RelatIvo Al Follow-up a LuNGo Termine Di Pazienti Con Stenosi Aortica Severa Valutati Per Sostituzione Valvolare Aortica Percutanea (TAVI).
Lead sponsor
University Hospital of Ferrara
Phase
Observational
Overall status
Enrolling by invitation
Start date
November 30, 2024
Completion date
November 30, 2035
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe aortic stenosis, tavi(transcatheter aortic valve implantation)